Navigation Links
Immucor Announces New Vice President, Operations
Date:1/19/2009

NORCROSS, Ga., Jan. 19 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Michael Pred has joined the Company as Vice President, Operations, responsible for overseeing all U.S. manufacturing operations.

Mr. Pred has more than 15 years pharmaceutical manufacturing experience with both Pfizer and Merck & Co. Most recently, he led all manufacturing in a multi-plant operation for vaccine production for Pfizer Animal Health. Prior to joining Pfizer, Mr. Pred held various manufacturing leadership roles at Merck. He spent seven years in the U.S. Navy, as a nuclear-trained submarine officer. Mr. Pred holds a B.S. in chemical engineering from the University of Wisconsin.

"With his strong working knowledge of manufacturing best practices and his proven commitment to excellence, Mike will help Immucor maintain our strong commitment to product quality and quality compliance while enhancing manufacturing efficiency," stated Dr. Gioacchino De Chirico.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com .


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
2. Immucor Closes BioArray Acquisition
3. Immucor Schedules Fiscal 2009 Guidance Call
4. Immucor Responding to FDA Warning Letter
5. Immucor Announces Record Fiscal Third Quarter Results
6. Immucor Schedules Third Quarter Earnings Release and Conference Call
7. Immucor, Inc. Adds Director to Board
8. Immucor Announces Update to Second Quarter Conference Call Number
9. Immucor, Inc. Appoints New Chief Financial Officer
10. Immucor Announces Record Fiscal First Quarter Revenues
11. Immucor Schedules First Quarter Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2017)... , ... April 23, 2017 , ... ... managed services announced the achievement of Cisco Select certification and SMB specialization. ... United States. , In earning the Select Certification, Altura fulfilled the ...
(Date:4/22/2017)... Juan Capistrano (PRWEB) , ... April 22, 2017 , ... The San Juan Capistrano ... recently released a parenting report outlining the need for summer camps to provide physical activities ... The Importance of Physical Activity In Summer Camps , With an increase in specialty camps ...
(Date:4/21/2017)... ... April 21, 2017 , ... Chicago plastic surgeon, Dr. Anil R. Shah, ... is a benign bony lump located on the forehead usually attributed to a facial ... sight and pain. Dr. Shah has discovered an approach that is minimally invasive. He ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies perfectly ... in the company’s esteemed VISION House demonstration project series. Manifesting the concept of right-sized ... resources they need to live affordably and abundantly without unduly taxing the resources of ...
(Date:4/21/2017)... ... 2017 , ... The American Medical Student Association (AMSA) will ... Education, from April 24 to April 28, 2017, dedicated to increasing awareness about ... mission of AWARE is to instill a compassionate, total health approach to treating ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 /PRNewswire/ ... ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron Ehlen ... the signing of a three-year exclusive sales representation ... a dedicated sales team to introduce Imprimis, ophthalmic ... focused in 13 states in the U.S. Midwest. Precision ...
(Date:4/18/2017)... 18, 2017 Research and Markets has ... States Molecular Imaging Equipment and Radiopharmaceuticals Market, Forecast to 2023" ... ... equipment revenues as well as growth in the number of ... value to market participants that design and manufacture molecular imaging ...
(Date:4/18/2017)... 2017 Recursion Pharmaceuticals , an emerging ... learning techniques to discover treatments for rare genetic diseases, ... as vice president of biology. Chong joins the ... Belgium , where as a principal ... high-dimensional biological approaches to the small molecule lead discovery ...
Breaking Medicine Technology: